In combination, evidence suggests that RYBP act as tumour suppressor gene in different solid tumours but as an oncogene in lymphoma and melanoma (Fig. 2); however, the precise underlying mechanisms of these opposing function remain to be clarified. This evidence concerns the gene RYBP and melanoma.